Leishmania and Leishmaniasis

Leishmania-related illnesses remain among the world’s deadliest neglected tropical diseases, affecting approximately 12 million people in 88 countries. The mortality rate is substantial, contributing to nearly two million disability-adjusted life years. As more is understood about this parasite and...

Full description

Saved in:
Bibliographic Details
Main Author: Kumar, Awanish. (Author, http://id.loc.gov/vocabulary/relators/aut)
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Published: New York, NY : Springer New York : Imprint: Springer, 2013.
Edition:1st ed. 2013.
Series:SpringerBriefs in Immunology, 3
Online Access:https://doi.org/10.1007/978-1-4614-8869-9
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Historical background of Leishmania and leishmaniasis
  • Risk factors and definition of the problem
  • Types of leishmaniasis
  • Global status of visceral leishmaniasis
  • Status of visceral leishmaniasis in India
  • Morphology and Life cycle of Leishmania donovani
  • Vectors and transmission of the disease
  • Clinical symptoms of visceral leishmaniasis
  • Control strategies of the disease
  • Leishmania/HIV co-infections
  • Host Immune response to Leishmania infection
  • Cross-immunity between different Leishmania species
  • Adoptive transfer of immunity
  • Cutaneous leishmaniasis
  • Mucocutaneous Leishmaniasis
  • Visceral Leishmaniasis
  • Post Kala-azar dermal Leishmaniasis
  • Drugs against leishmaniasis
  • Antimonials and Leishmaniasis
  • SAG treatment, failure and resistance in Leishmania
  • Vaccines against Leishmaniasis
  • Strategy in practice for vaccine development against Leishmanisis.